BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Natco Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524816
ISIN Demat
INE987B01026
Book Value (Rs)
461.79599
NSE Symbol
NATCOPHARM
Divident Yield %
0.72
Market Cap
(Rs In Cr.)
14,937
P/E (TTM)
9.84
EPS (TTM)
84.75
Face Value
(Rs)
2
Back
Natco Pharma consolidated net profit declines 23.46% in the September 2025 quarter
14-Nov-25   Hrs IST

Net profit of Natco Pharma declined 23.46% to Rs 518.40 crore in the quarter ended September 2025 as against Rs 677.30 crore during the previous quarter ended September 2024. Sales declined 0.59% to Rs 1363.00 crore in the quarter ended September 2025 as against Rs 1371.10 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales1363.001371.10 -1
OPM %42.4958.66 -
PBDT666.10864.00 -23
PBT613.70818.20 -25
NP518.40677.30 -23

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)